Indian drug companies are set to revolutionize diabetes treatment with affordable generic versions of Empagliflozin, ...

For individuals with type 2 diabetes (T2D), semaglutide is associated with a modestly increased risk for nonarteritic anterior ischemic optic neuropathy (NAION).

Adults with T2D taking semaglutide, other glucagon-like peptide 1 receptor agonists (GLP-1 RAs; dulaglutide and exenatide), or non-GLP-1 RA medications (empagliflozin, sitagliptin, and glipizide ...

Wegovy (semaglutide) is a brand-name subcutaneous injection pen. It’s prescribed for weight loss and to lower cardiovascular risks. Wegovy interacts with some other drugs and certain supplements ...

and 832,295 with glipizide. Of the 43,620 new users of semaglutide in Optum's de-identified Clinformatics Data Mart Database, 56% were ages 50 to 69, 61% were women, and 66% were white.

When you have type 1 or type 2 diabetes, dangerous spikes in blood glucose (severe hyperglycemia) may mean you need to reduce blood sugar levels quickly. If you don't, you could be at risk for ...

Eun Lee, MD Changing diabetes medications isn't something you should take lightly. In some cases, you may need to do so ...